Position in NVS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,484
-$4,097 QoQ
Shares Held
49
-41.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Basepoint Wealth LLC holds $3,452,969 across 11 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,960 | $1,751,414 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
8,570 | $493,803 | |
| 3 | JNJ |
Johnson & Johnson
|
1,133 | $287,748 | |
| 4 | PFE |
Pfizer Inc
|
10,811 | $260,328 | |
| 5 | BIIB |
Biogen Inc.
|
1,074 | $232,048 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,478 | $189,923 | |
| 7 | AMGN |
Amgen Inc
|
273 | $98,858 | |
| 8 | LLY |
ELI LILLY & Co
|
55 | $65,968 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,484 | 49 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,581 | 84 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||